Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

949 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Analysis of severe acute respiratory syndrome in Beijing].
Jiang TJ, Zhou XZ, Zhao M, Zhou ZP, Jiang SC, Ye WH, Li YG, Zhao JM, Mao YL, Ma W, Qu F, Wang Y, He J, Nie WM, Zhang YH, Xie YX, Yan HY. Jiang TJ, et al. Among authors: li yg. Zhonghua Nei Ke Za Zhi. 2003 Jun;42(6):369-72. Zhonghua Nei Ke Za Zhi. 2003. PMID: 12895317 Chinese.
Genetic variation of SARS coronavirus in Beijing Hospital.
Xu D, Zhang Z, Chu F, Li Y, Jin L, Zhang L, Gao GF, Wang FS. Xu D, et al. Emerg Infect Dis. 2004 May;10(5):789-94. doi: 10.3201/eid1005.030875. Emerg Infect Dis. 2004. PMID: 15200810 Free PMC article.
Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trial.
Li TT, Zhang B, Fang H, Shi M, Yao WQ, Li Y, Zhang C, Song J, Huang L, Xu Z, Yuan X, Fu JL, Zhen C, Zhang Y, Wang ZR, Zhang ZY, Yuan MQ, Dong T, Bai R, Zhao L, Cai J, Dong J, Zhang J, Xie WF, Li Y, Shi L, Wang FS. Li TT, et al. EBioMedicine. 2023 Jun;92:104600. doi: 10.1016/j.ebiom.2023.104600. Epub 2023 May 5. EBioMedicine. 2023. PMID: 37149930 Free PMC article. Clinical Trial.
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trial.
Shi L, Yuan X, Yao W, Wang S, Zhang C, Zhang B, Song J, Huang L, Xu Z, Fu JL, Li Y, Xu R, Li TT, Dong J, Cai J, Li G, Xie Y, Shi M, Li Y, Zhang Y, Xie WF, Wang FS. Shi L, et al. EBioMedicine. 2022 Jan;75:103789. doi: 10.1016/j.ebiom.2021.103789. Epub 2021 Dec 25. EBioMedicine. 2022. PMID: 34963099 Free PMC article. Clinical Trial.
949 results